Compass Pathways Plc (CMPS NASDAQ) stock market data APIs
$11.763
0.35(3%)
as of July 20, 2026
Try our APIs with
free plan!
Compass Pathways Plc Financial Data Overview
Price chart is built with
Anychart
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Prev. Close
11.763
Open
12.1117
High
12.3736
Low
11.7491
52 wk Range
3.92-15.4
Market Cap
1 626 M
Shares Outstanding
135 M
EPS
-0.3
Beta
2.487
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Compass Pathways Plc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Compass Pathways Plc data using free add-ons & libraries
Get Compass Pathways Plc Fundamental Data
Compass Pathways Plc Fundamental data includes:
- Net Revenue:
- EBITDA: -174 316 000
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-13
- EPS/Forecast: -0.31
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Compass Pathways Plc News
New
Notable healthcare headlines for the week: UnitedHealth, J&J, and Intuitive Surgical in focus
Wall Street's major averages ended lower on Friday as global technology stocks declined, led by semiconductors and the debut of Moonshot AI's Kimi-K3, which dragged down investor sentiment. The bench...
Cathie Wood buys $36.1 million of tumbling tech stock
Cathie Wood, CEO of Ark Investment Management, is known for buying high-growth stocks soon after they go public, especially when share prices pull back after an early rally. That's exactly what she's...
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion
AtaiBeckley (NASDAQ:ATAI), a clinical-stage mental health and psychedelic drug developer, closed at $7.15, up 33.4%. Eli Lilly's (NYSE:LLY) announced acquisition drove the move, and investors are watc...
Why Psychedelic stocks are surging today
Investing.com -- Shares of psychedelic drug developers are surging premarket on Thursday after Eli Lilly announced a definitive agreement to acquire AtaiBeckley Inc., validating the sector and lifting...
Get Compass Pathways Plc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
